More Videos
SPECIAL REPORT
MOST SHARED
- Seeking Innovation in Health Care
- Cramer: 5 Earnings Reports to Watch Next Week
- Driving Health Care Innovation
- Downturn is Prime Time for Airport Infrastructure Projects
- Next Week’s Top IPO
- Hedge Fund Billionaire Paulson Reports New Citi Stake
- Gold Rises, Nears Record High as Dollar Drops
- Has Twitter's Finest Hours (Seconds) Come and Gone?
- Microsoft's Bill Gates Praises Apple's Steve Jobs For 'Saving the Company'
- Web Extra: Where Will The Next Bull Come From?
- Dollar is Not Plunging—So 'Calm Down': Market Strategist
- Strategists Say Markets Have More Upside — But How Much?
- Hirschhorn: Risk-Averse Traders
- Roginsky: A Funny Thing Happened on the Way to Financial Reform
- This Year's Biggest Thanksgiving Leftover: Cash
- TV Series Inks Unique Deal For Fight
- First Time Buyers Rescue Housing: Realtors
- Dollar General Trades Higher After Its IPO
- Fed Reform? Not So Fast.
- Oil Next Week: What Traders Will Be Watching
- Hedge Fund Billionaire Paulson Reports New Citi Stake
- Cramer: 5 Earnings Reports to Watch Next Week
- Court Rejects 'Clawbacks' for Alleged Stanford Victims
- Tax Credit Sparking First-Time Home Sales: Realtors
- Investors Cut Back US Stocks for Bigger Growth Abroad
- Cities With the Most Home Price Reductions
- White House Plans to Freeze Spending to Cut Deficit
- This Year's Biggest Thanksgiving Leftover: Cash
- Oil Next Week: What Traders Will Be Watching
RSS FEED
Pharma's Market
Text Size 
Here are some of the video clips I've done today on ASCO (American Society of Clinical Oncology) conference in Chicago. It's the world's biggest cancer conference and Wall Street's most keenly-watched medical meeting.
The clips are in order, with most recent at the top.
Highlights of the conference.
A promising brain cancer vaccine that has shown new positive test results, with John Sampson, Duke University Medical Center.
A breakthrough for patients suffering from brain cancer.
Discussing breakthroughs in drug cancer drugs and a company outlook, with Sol Barer, Celgene CEO.
ImClone's Erbitrux lung cancer drug is grabbing the spotlight.
Researchers will unveil new clinical trial results on a promising treatment for brain cancer.
An outlook on Genentech from ASCO, with Dr. Susan Desmond-Hellmann, former oncologist.
Deatils on the conference.
Questions? Comments?
Data is a real-time snapshot *Data is delayed at least 15 minutes